Search Results

This Data Spotlight from the Treatment Episode Data Set (TEDS) focuses on substance abuse treatment admissions during 2010 among college students who have co-occuring mental disorders.

This Data Spotlight from the Treatment Episode Data Set (TEDS) focuses on substances of abuse among military personnel and veterans aged 21 to 39 who were admitted to substance abuse treatment during 2010.

This report presents data from the Treatment Episode Data Set (TEDS) by Census division and State or jurisdiction for admissions in 2011, and trend data for 2001 to 2011. It provides information on the demographic and substance abuse characteristics of admissions to treatment aged 12 and older for abuse of...

These detailed tables present totals and prevalence estimates of risk and protective factors regarding substance use from the 2012 National Survey on Drug Use and Health (NSDUH). The factors include perceptions of 1) risk of substance use, 2) availability of substances, 3) parental disapproval of youth substance use, 4) peer...

These detailed tables present totals and prevalence estimates of substance use initiation from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants...

These detailed tables present totals and prevalence estimates of substance dependence/abuse and treatment need/receipt from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs, marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives, and alcohol. Results...

This report compares estimates of youth substance use from the 2002 to 2008 National Survey on Drug Use and Health (NSDUH) with estimates of similar measures from Monitoring the Future (MTF) and the Youth Risk Behavior Survey (YRBS). Substances covered include cigarettes, alcohol, marijuana, cocaine, heroin, ecstasy, and inhalants. Results...

A Treatment Episode Data Set (TEDS) report that provides a unique national perspective of the characteristics associated with people coming to substance abuse treatment with concurrent benzodiazepine and narcotic pain reliever abuse, using data from 2000-2010.

This short report uses data from the 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs), the 2010 Treatment Episode Data Set (TEDS), the 2010 National Survey of Substance Abuse Treatment Services (N-SSATS), and the 2011 Drug Abuse Warning Network (DAWN) to present facts about adolescent substance use...

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of central nervous system stimulants among adults age 18 to 34 increase between 2005 and 2011.

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of phamaceuticals by gender among older adolescents age 12 to 17 from year 2010.

These detailed tables are population illicit drug use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Illicit drugs include marijuana, cocaine, crack, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type psychotherapeutics, including pain relievers, tranquilizers, stimulants, and sedatives. Results are provided for...

This issue of the National Survey on Drug Use and Health (NSDUH) Report presents combined 2002 to 2010 data to examine substance use patterns among

This report shows the estimated number of emergency department visits where the patient was intentionally poisoned or drugged by another person in 2011. The report specifically talks about gender, the types of drugs involved, the role of alcohol, and the outcome of the visits.

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits involving phencyclidine (PCP) between 2005 and 2011. The report specifically talks about age groups, gender and other drugs such as marijuana, cocaine, heroin and pharmaceuticals and trends over time.